These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 26453486

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J, Piersiala K, Klimza H, Wierzbicka M.
    Otolaryngol Pol; 2018 Jun 12; 72(4):1-8. PubMed ID: 30190442
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis.
    Hoesli RC, Thatcher AL, Hogikyan ND, Kupfer RA.
    JAMA Otolaryngol Head Neck Surg; 2020 Mar 01; 146(3):231-236. PubMed ID: 31895450
    [Abstract] [Full Text] [Related]

  • 25. Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
    Grasso M, Remacle M, Bachy V, Van Der Vorst S, Lawson G.
    Eur Arch Otorhinolaryngol; 2014 Nov 01; 271(11):2983-90. PubMed ID: 24756616
    [Abstract] [Full Text] [Related]

  • 26. Long-term Outcomes of Juvenile Onset Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
    Yang Q, Li Y, Ma L, Xiao Y, Wang H, Ding Y, Hu R, Wang X, Meng L, Wang J, Xu W.
    Laryngoscope; 2021 Jul 01; 131(7):EE2277-E2283. PubMed ID: 33411979
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. HPV genotype is a prognosticator for recurrence of respiratory papillomatosis in children.
    Nogueira RL, Küpper DS, do Bonfim CM, Aragon DC, Damico TA, Miura CS, Passos IM, Nogueira ML, Rahal P, Valera FCP.
    Clin Otolaryngol; 2021 Jan 01; 46(1):181-188. PubMed ID: 32869523
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
    Broekema FI, Dikkers FG.
    Eur Arch Otorhinolaryngol; 2008 Aug 01; 265(8):871-9. PubMed ID: 18458927
    [Abstract] [Full Text] [Related]

  • 33. Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
    Meacham RK, Thompson JW.
    Ear Nose Throat J; 2017 Feb 01; 96(2):69-74. PubMed ID: 28231366
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
    Rivière F, Gille T, Le Tinier JY, Gharbi N, Khalil A, Wislez M, Cadranel J.
    Scand J Infect Dis; 2011 Feb 01; 43(2):112-4. PubMed ID: 21039305
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.